These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33151675)

  • 21. Vacuolar-type H(+)-ATPase inhibitory activity of synthetic analogues of the concanamycins: is the hydrogen bond network involving the lactone carbonyl, the hemiacetal hydroxy group, and the C-19 hydroxy group essential for the biological activity of the concanamycins?
    Yoshimoto Y; Jyojima T; Arita T; Ueda M; Imoto M; Matsumura S; Toshima K
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3525-8. PubMed ID: 12443768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vacuolar H(+)-ATPase and plasma membrane H(+)-ATPase contribute to the tolerance against high-pressure carbon dioxide treatment in Saccharomyces cerevisiae.
    Watanabe T; Furukawa S; Kitamoto K; Takatsuki A; Hirata R; Ogihara H; Yamasaki M
    Int J Food Microbiol; 2005 Nov; 105(2):131-7. PubMed ID: 16102865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
    Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
    J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector.
    Dixon N; Páli T; Kee TP; Ball S; Harrison MA; Findlay JB; Nyman J; Väänänen K; Finbow ME; Marsh D
    Biophys J; 2008 Jan; 94(2):506-14. PubMed ID: 17872954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Archazolid and apicularen: novel specific V-ATPase inhibitors.
    Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
    BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles.
    Marceau F; Bawolak MT; Bouthillier J; Morissette G
    Drug Metab Dispos; 2009 Dec; 37(12):2271-4. PubMed ID: 19773536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel marine and microbial natural product inhibitors of vacuolar ATPase.
    Beutler JA; McKee TC
    Curr Med Chem; 2003 May; 10(9):787-96. PubMed ID: 12678782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Evaluation of Cleistanthin A Derivatives as Potent Vacuolar H(+) -ATPase Inhibitors.
    Zhao Y; Lu Y; Ma J; Zhu L
    Chem Biol Drug Des; 2015 Oct; 86(4):691-6. PubMed ID: 25677205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding assays of inhibitors towards selected V-ATPase domains.
    Fernandes F; Loura LM; Fedorov A; Dixon N; Kee TP; Prieto M; Hemminga MA
    Biochim Biophys Acta; 2006 Nov; 1758(11):1777-86. PubMed ID: 16996024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The function of vacuolar ATPase (V-ATPase) a subunit isoforms in invasiveness of MCF10a and MCF10CA1a human breast cancer cells.
    Capecci J; Forgac M
    J Biol Chem; 2013 Nov; 288(45):32731-32741. PubMed ID: 24072707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in secretion of glial cell line-derived neurotrophic factor from glial cell lines by inhibitors of vacuolar ATPase.
    Nishiguchi M; Tokugawa K; Yamamoto K; Akama T; Nozawa Y; Chaki S; Ueki T; Kameo K; Okuyama S
    Neurochem Int; 2003 May; 42(6):493-8. PubMed ID: 12547648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
    Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
    Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.
    Cotter K; Capecci J; Sennoune S; Huss M; Maier M; Martinez-Zaguilan R; Forgac M
    J Biol Chem; 2015 Feb; 290(6):3680-92. PubMed ID: 25505184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in subunit C of the vacuolar ATPase confer resistance to bafilomycin and identify a conserved antibiotic binding site.
    Bowman BJ; Bowman EJ
    J Biol Chem; 2002 Feb; 277(6):3965-72. PubMed ID: 11724795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissection of autophagy in tobacco BY-2 cells under sucrose starvation conditions using the vacuolar H(+)-ATPase inhibitor concanamycin A and the autophagy-related protein Atg8.
    Yano K; Yanagisawa T; Mukae K; Niwa Y; Inoue Y; Moriyasu Y
    Plant Signal Behav; 2015; 10(11):e1082699. PubMed ID: 26368310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of vacuolar H+-ATPase activity in organelles signals ubiquitination and endocytosis of the yeast plasma membrane proton pump Pma1p.
    Smardon AM; Kane PM
    J Biol Chem; 2014 Nov; 289(46):32316-32326. PubMed ID: 25271159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells.
    Bartel K; Müller R; von Schwarzenberg K
    J Biol Chem; 2019 Nov; 294(46):17239-17248. PubMed ID: 31604821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase.
    Dreisigacker S; Latek D; Bockelmann S; Huss M; Wieczorek H; Filipek S; Gohlke H; Menche D; Carlomagno T
    J Chem Inf Model; 2012 Aug; 52(8):2265-72. PubMed ID: 22747331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iejimalide C is a potent V-ATPase inhibitor, and induces actin disorganization.
    Kazami S; Takaine M; Itoh H; Kubota T; Kobayashi J; Usui T
    Biol Pharm Bull; 2014; 37(12):1944-7. PubMed ID: 25451843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid.
    Persch E; Basile T; Bockelmann S; Huss M; Wieczorek H; Carlomagno T; Menche D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7735-8. PubMed ID: 23122818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.